Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase NA 3Phase 1 3Phase 1/2 2Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 3Leukemia, Myeloid, Acute 3Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Lymphoma 1Leukemia, Myeloid 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

Rituximab 49Cyclophosphamide 28venetoclax 24Bendamustine Hydrochloride 24obinutuzumab 22ibrutinib 21Chlorambucil 20fludarabine 16fludarabine phosphate 15idelalisib 13acalabrutinib 11pirtobrutinib 7ofatumumab 7zanubrutinib 5Vincristine 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Cyclosporine 5Radiotherapy 4Prednisone 4Doxorubicin 4duvelisib 3Whole-Body Irradiation 3Specimen Handling 3Methotrexate 3Lenalidomide 3Filgrastim 3Epoetin Alfa 3Cyclosporins 3Biopsy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Lymphocytic, Chronic, B-Cell × thymoglobulin × Clear all
NCT01217723 2010-10-08

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

McMaster University

Phase 3 Unknown
198 enrolled
LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡